Categories: DrugLegalTechProduct
We develop and commercialize innovative oncology products for women’s and pediatric cancers. Our oncology solutions deliver life-saving treatments to patients across the world
Investors 1
Funding Rounds 1
| Date | Series | Amount | Investors |
| 03.06.2020 | Series A | $8.3M | - |
Mentions in press and media 6
| Date | Title | Description | Source |
| 10.11.2020 | Shorla Pharma Announces New Board Members, John Moloney and ... |
DUBLIN and CLONMEL, Ireland, Nov. 10, 2020 /PRNewswire/ -- Shorla Pharma Limited ('Shorla'), an Ir... | prnewswire... |
| 03.06.2020 | Ireland's Shorla nabs $8.3M to bring improved cancer meds to... | When Opko Health bought Ireland’s EirGen in 2015, colleagues Sharon Cunningham and Orlaith Ryan wast... | fiercebiot... |
| 03.06.2020 | Shorla Pharma Raises $8.3M in Series A Funding Round | Shorla Pharma, an Irish specialty pharmaceutical company, completed an $8.3m Series A financing.
Th... | finsmes.co... |
| - | Shorla Announces Partnership with EVERSANA to Support the La... | Cambridge, Massachusetts, USA. 17 August, 2021. Seroba’s portfolio company, Shorla Pharma (‘Shorla’)... | seroba-lif... |
| - | Shorla Pharma Closes $8.3m Series A Funding Round | Dublin and Clonmel, Ireland. June 4, 2020. Shorla Pharma Limited (‘Shorla’), an Irish specialty phar... | seroba-lif... |
| - | Shorla Pharma Announces FDA Filing Acceptance and Priority R... | Clonmel, Ireland. April 23, 2021. Seroba’s portfolio company, Shorla Pharma Limited (‘Shorla’), a sp... | seroba-lif... |
Reviews 0
